Product category:
Analytical, statistical and report generating software
News Release from: Ocimum Biosolutions | Subject: Genchek
Edited by the Laboratorytalk Editorial
Team on 11 August 2004
The next step in the sequence
"Sequence analysis is a cornerstone of modern molecular genetics, yet it is difficult to provide researchers with an experience that is meaningful and cost effective"
Ocimum Biosolutions has licensed Genchek, comprehensive sequence analysis tool, to University of Washington, University of Virginia, Alcorn State University and Acuity Pharmaceuticals Ocimum's CEO Anuradha Acharya remarked, "Genchek is our first and most mature product with almost four years of development work
This article was originally published on Laboratorytalk on 9 Aug 2004 at 8.00am (UK)
Related stories
Software firm makes two sales
Ocimum Biosolutions licenses gene expression analysis program to Bioniche Therapeutics Research Center and the University of Ottawa
"The new version of Genchek is very comprehensive and can replace multiple tools used by researchers.
"We are proud to add these prestigious organisations to our list of clients.
"Sequence analysis is a cornerstone of modern molecular genetics, yet it is difficult to provide researchers with an experience that is meaningful and cost effective.
"Genchek, a comprehensive, multi-platform, cost-effective, sequence analysis software package, is capable of handling and analysing high throughput biological data.
"We expect that Genchek will enhance their research work".
Financial details of the deals were not disclosed.
• Ocimum Biosolutions: contact details and other news
• Email this article to a colleague
• Register for the free Laboratorytalk email newsletter
• Laboratorytalk Home Page
Search the Pro-Talk network of sites
